Look at our new launches, GSK urges, as its respiratory woes steal the limelight

Look at our new launches, GSK urges, as its respiratory woes steal the limelight

Source: 
Fierce Pharma
snippet: 

GlaxoSmithKline is as upbeat as ever about the key launches it has underway—including its new shingles vaccine Shingrix—but take a look at the business as a whole, and you'll find sore spots.

None so sore as the company's crucial respiratory franchise, but its HIV business isn't pain-free either, analysts pointed out Wednesday after the company released first-quarter earnings.